01 1Deva Holding AS
01 1DASATINIB
01 1Turkey
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-09-11
Pay. Date : 2024-05-28
DMF Number : 39111
Submission : 2024-08-27
Status : Active
Type : II
20
Deva Holding As, based in Turkey, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for First company in Turkey to manufacturer APIs & an ideal partner for multi-layered & Complex Chemical Synthesis.
One of their notable products is DASATINIB, with a corresponding US DMF Number 39111.
Remarkably, this DMF maintains an Active status since its submission on August 27, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 11, 2024, and payment made on May 28, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
